News

pharmaphorum3d
Merck puts a price on its SpringWorks takeover bid
So far, SpringWorks – which was spun out of Pfizer in 2017 and has recently received FDA approval for a second therapy for a ...
Yahoo Finance3d
German pharma giant Merck close to takeover of US cancer specialist
Germany's Merck is on the verge of a billion-euro takeover of US biopharmaceutical company Springworks Therapeutics, with the sides now in "advanced talks" about a purchase, Merck said on Friday ...
Wall Street Journal3d
Germany’s Merck Nears Roughly $3.5 Billion Deal for SpringWorks
The two parties are discussing a deal around $47 per share, Merck said in a statement Thursday, confirming an earlier report in The Wall Street Journal. Merck said no final agreement had been made ...
Merck posts higher profit, puts tariffs cost at $200 million
Merck on Thursday said its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales, ...
Devdiscourse1d
Global Health Headlines: Mergers, Outbreaks, and Judicial Decisions Shake the Sector
Recent health news highlights Germany's Merck's acquisition talks with SpringWorks, U.S. Justice Department's disbanding of a ...
Standard-Journal6h
Merck KGaA, Darmstadt, Germany, to Acquire US Biopharma Company SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business
Merck KGaA, Darmstadt, Germany (DAX: MRK), a leading science and technology company, and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a Stamford, Connecticut-based commercial-stage biopharmaceutical ...
Curiosity Cube 2025: MilliporeSigma’s Mobile Science Labs Tour Globally to Bring STEM Education to Students
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology ...